BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 2005;15:140-7. [PMID: 15449000 DOI: 10.1007/s00330-004-2508-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010;32:903-913. [PMID: 20882621 DOI: 10.1002/jmri.22333] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wersebe A, Wiskirchen J, Decker U, Schick F, Dietz K, M??ller-schimpfle M, Claussen CD, Pereira PL. Comparison of Gadolinium-BOPTA and Ferucarbotran-Enhanced Three-Dimensional T1-Weighted Dynamic Liver Magnetic Resonance Imaging in the Same Patient: . Investigative Radiology 2006;41:264-71. [DOI: 10.1097/01.rli.0000188359.72928.0f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
3 Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-30. [DOI: 10.1007/s00330-007-0602-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
4 Lencioni R, Crocetti L, Della Pina MC, Cioni D. Guidelines for imaging focal lesions in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2014;2:697-703. [DOI: 10.1586/17474124.2.5.697] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
5 Di Pietropaolo M, Briani C, Federici GF, Marignani M, Begini P, Delle Fave G, Iannicelli E. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules. Clin Imaging 2015;39:468-75. [PMID: 25748089 DOI: 10.1016/j.clinimag.2014.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hamer OW, Schlottmann K, Sirlin CB, Feuerbach S. Technology Insight: advances in liver imaging. Nat Rev Gastroenterol Hepatol 2007;4:215-28. [DOI: 10.1038/ncpgasthep0766] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
7 Rosenkrantz AB, Mannelli L, Kim S, Babb JS. Gadolinium-Enhanced Liver Magnetic Resonance Imaging Using a 2-Point Dixon Fat-Water Separation Technique: Impact Upon Image Quality and Lesion Detection. Journal of Computer Assisted Tomography 2011;35:96-101. [DOI: 10.1097/rct.0b013e3181f3d57e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-1266. [PMID: 19697104 DOI: 10.1007/s11547-009-0439-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
9 Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, Berger BD, O'Connor JK, Goldstein RM. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008;21:266-280. [PMID: 18628926 DOI: 10.1080/08998280.2008.11928410] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
10 Glockner JF. Hepatobiliary MRI: current concepts and controversies. J Magn Reson Imaging. 2007;25:681-695. [PMID: 17352396 DOI: 10.1002/jmri.20844] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
11 Choi J, Choi J, Kim M, Lim JS, Park MS, Kim JH, Chung YE. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 2010;31:571-8. [DOI: 10.1002/jmri.22076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009;29:636-40. [DOI: 10.1002/jmri.21689] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
13 Nakai M, Sato M, Sahara S, Takasaka I, Kawai N, Minamiguchi H, Tanihata H, Kimura M, Takeuchi N. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol 2009;32:62-9. [PMID: 18987911 DOI: 10.1007/s00270-008-9462-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
14 Yoo HJ, Lee JM, Lee MW, Kim SJ, Lee JY, Han JK, Choi BI. Hepatocellular Carcinoma in Cirrhotic Liver: Double-Contrast-Enhanced, High-Resolution 3.0T-MR Imaging With Pathologic Correlation: . Investigative Radiology 2008;43:538-46. [DOI: 10.1097/rli.0b013e3181768d96] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]